Assembly Biosciences (ASMB) Share-based Compensation (2010 - 2026)

Assembly Biosciences' Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 56.74% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $404000.0, a 79.16% decrease from a year earlier, with the FY2024 full-year figure at $2.0 million, down 61.59% from the prior year.
• Share-based Compensation grew to $1.1 million in Q1 2026 per ASMB's latest filing, from -$3.2 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $1.8 million in Q1 2023 and bottomed at -$3.2 million in Q4 2025.
• The 5-year median for Share-based Compensation is $1.0 million (2023), against an average of $798812.5.
• Across the five-year window, Share-based Compensation surged 604.55% in 2022 and plunged 698.01% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $1.6 million in 2022, then tumbled by 38.37% to $959000.0 in 2023, then tumbled by 142.02% to -$403000.0 in 2024, then plunged by 698.01% to -$3.2 million in 2025, then soared by 134.7% to $1.1 million in 2026.
• Per Business Quant, the three latest ASMB Share-based Compensation figures stand at $1.1 million (Q1 2026), -$3.2 million (Q4 2025), and $1.7 million (Q3 2025).